Vivelle-dot and Thrombosis - a phase IV clinical study of FDA data

Summary:

Thrombosis is reported as a side effect among people who take Vivelle-dot (estradiol), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Synthroid, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Thrombosis when taking Vivelle-dot. It is created by eHealthMe based on reports of 3,271 people who have side effects when taking Vivelle-dot from the FDA, and is updated regularly.

What is Vivelle-dot?

Vivelle-dot has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 3,545 Vivelle-dot users. Check the latest studies of Vivelle-dot.

What is Thrombosis?

Thrombosis (formation of a blood clot inside a blood vessel) is found to be associated with 1,809 drugs and 2,052 conditions by eHealthMe. Check the latest studies of Thrombosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

3,271 people reported to have side effects when taking Vivelle-dot.
Among them, 19 people (0.58%) have Thrombosis.

Among these 19 people:

How long have people been on Vivelle-dot when they have Thrombosis? *

What is the gender of people who have Thrombosis when taking Vivelle-dot? *

female: 100 %
male: 0.0 %

What is the age of people who have Thrombosis when taking Vivelle-dot? *

What are other drugs people take besides Vivelle-dot? *

What are other side effects people have besides Thrombosis? *

Pain: 7 people, 36.84%
Weight Increased: 6 people, 31.58%
Heart Attack: 6 people, 31.58%
Fall: 6 people, 31.58%
Chest Pain: 4 people, 21.05%
Dizziness: 4 people, 21.05%
Fatigue (feeling of tiredness): 4 people, 21.05%
Migraine (headache): 4 people, 21.05%
Breast Discoloration: 3 people, 15.79%
Blood Urine Present: 3 people, 15.79%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 3 people, 15.79%
Thyroid Diseases: 2 people, 10.53%
Primary Immunodeficiency Syndrome: 2 people, 10.53%
Pelvic Pain: 2 people, 10.53%
High Blood Pressure: 2 people, 10.53%
Cardiac Disorder: 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.26%
Pain: 1 person, 5.26%
Joint Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Vivelle-dot and have Thrombosis?

- Check whether Thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vivelle-dot:

Vivelle-dot (3,545 reports)

Thrombosis treatments and more:

Thrombosis (115,528 reports)

Browse all side effects of Vivelle-dot:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombosis:

Thrombosis (1,809 drugs)

Browse all the conditions that are associated with Thrombosis:

Thrombosis (2,052 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on estradiol (the active ingredients of Vivelle-dot) and Vivelle-dot (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.